Patient Education & Health Promotion PDF

Patient education and Health promotion page:1085 Prevention is a valuable strategy to reduce the incidence, morbidly, and mortality of meningitis. HIB and pneumococcal vaccines have proved to be effective in lowering the attack rate of meningitis in all ages, they sho...

Patient education and Health promotion page:1085 Prevention is a valuable strategy to reduce the incidence, morbidly, and mortality of meningitis. HIB and pneumococcal vaccines have proved to be effective in lowering the attack rate of meningitis in all ages, they should be strongly encouraged for infants. PCV 23 should be given to immunocompromised, aslpenic, and chronic diseases such as HF, lung diseases, diabetes, tobacco use, liver disease and alcoholism. o PCV 13 and PPSV 23 are now recommended for adults over 65. MCV 4 is routinely given to children aged 11-12. A booster is given at 16 because the protection wanes after 5 years, and rates of meningitis peak at ages 16-21. o MCV 4 should be given to adults living in college dorms, military recruits, complement deficiency or asplenia, spending time in endemic arras, and scientists working with the casual organism. o Chemoprophylaxis for close contacts of patients with N. meningitides or H. influenzae infections include rifampin 600 mg BID for 2 days, ceftriaxone 250 mg IM single dose, or ciprofloxacin 500 mg single dose. Chapter 222 vaccine for meningitis page 1393 FDA approved HPV vaccine for girls 9-26 and males 9-21. Protects against HPV that can cause cervical, vaginal, vulvar, and anal cancers. Hep B vaccine is available for all age groups to prevent HBV infection. Chapter 51: Indication for tetanus immunization Tetanus immunizations should be reviewed for all patients with after any type of tissue trauma. If immunization state is unknown, not given a booster in 10 years, or if the patient received < 3 lifetime doses, Td toxoid and TIG should be given. All age groups are currently recommended to receive one dose of Tdap immunization. Once Tdap is given to an adult, one dose of Td is recommended to patients with tetanus prone (and contaminated) wounds if the previous immunization was > 5 years ago. o Tetanus prone wounds: Td and TIG if < 3 lifetime doses. If > 3 lifetime doses, then just Td if > 5 years since booster. o Non tetanus prone wounds: Td if < 3 lifetime doses. If > 3 lifetime doses, then just Td if > 10 years since booster.